Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7425 p539
4 November 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Poor results for methadone programme in Scotland, report researchers

Questions over the effectiveness of the methadone programme in Scotland were posed this week by researchers from Glasgow.

Results from the Drug Outcome Research in Scotland (DORIS) study show that only 8 per cent of drug users become drug-free after nearly three years on a methadone programme. The researchers, led by Neil McKeganey, centre for drug misuse research, University of Glasgow, comment that this level of abstinence is substantially lower than that identified in England.

The study involved 695 injecting drug users who accessed drug treatment services in Scotland. They were surveyed 33 months after starting treatment to find out how many were drug-free for the 90 days before the survey interview.

The results show 6 per cent of women and 9 per cent of men were drug-free. Those who were abstinent were more likely to have been on an educational course, be in employment or have experienced residential rehabilitation.

The researchers then compared the results with those of the National Drug Treatment Outcome Study in England. It defined abstinence to include use of prescribed substitute methadone. When the researchers applied this definition to the Scottish study population, abstinence levels were 33 per cent for people in residential rehabilitation and 11 per cent for those on methadone maintenance. This compared with 36 per cent and 24 per cent, respectively, in England. The study will be published in Drugs: education, prevention and policy.

Back to Top


©The Pharmaceutical Journal